Processing your request

please wait...

Case Page


Case Status:    ONGOING    
On or around 11/02/2018 (Ongoing date of last review)

Filing Date: November 02, 2018

According to the Complaint, India Globalization Capital, Inc. ("IGC" or the Company) operates two distinct business segments. One segment develops and commercializes cannabinoid based alternative therapies for indications such as Alzheimer's
disease, Parkinson's disease, and pain. The Company's second segment, operated since its inception, is a legacy business that involves trading commodities and heavy equipment rental.

The Complaint alleges that during the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: IGC was engaged in ventures or promotions which it had not developed to commercial stage; IGC or its management had engaged in operations contrary to the public interest; and that as a result of the foregoing, IGC’s public statements were materially false and misleading at all relevant times and led to IGC's suspension from trading on the NYSE American Stock Exchange, and the commencement of delisting proceedings from that exchange.


Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: United States


Ticker Symbol: IGC
Company Market: New York SE
Market Status: Public (Listed)

About the Company & Securities Data

"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: D. Maryland
DOCKET #: 18-CV-03396
JUDGE: Hon. Paul W. Grimm
DATE FILED: 11/02/2018
CLASS PERIOD END: 10/29/2018
  1. Tydings & Rosenberg LLP
    100 East Pratt Street, Tydings & Rosenberg LLP, MD 21202
    410.752.9700 410.757.5460 ·
  2. Wolf Haldenstein Adler Freeman & Herz LLP (New York)
    270 Madison Avenue, Wolf Haldenstein Adler Freeman & Herz LLP (New York), NY 10016
    212.545.4600 212.686.0114 ·
No Document Title Filing Date
—Reference Complaint Complaint Related Data is not available
—Related District Court Filings Data is not available